The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update: Factom Inc.

9 Jul 2020 07:00

RNS Number : 4644S
FastForward Innovations Limited
09 July 2020
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

9 July 2020

 

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

 

Investee Company Update: FastForward Innovations response to Factom Inc. filing for Chapter 11 reorganisation

 

FastForward Innovations Ltd announces that further to its announcement on 22 June 2020 confirming that investee company Factom, Inc. ("Factom") has initiated a bankruptcy proceeding in the United States Bankruptcy Court for the District of Delaware (the "Delaware Court") seeking reorganisation under Chapter 11 of the US Bankruptcy Code, FastForward has filed its appearance in Factom's bankruptcy case, and also motions requesting that the Delaware Court: (i) dismiss Factom's bankruptcy case so that a receiver may be appointed to liquidate Factom's assets in a Texas state court; (ii) alternatively, to convert Factom's bankruptcy case to a liquidation proceeding under Chapter 7 of the US Bankruptcy Code, or (ii) alternatively, to transfer Factom's bankruptcy case from the Delaware Court to the US Bankruptcy Court for the Western District of Texas, Austin Division (the "Texas Court"). With these filings, FastForward also responds to certain statements made in the proposed plan of reorganisation filed by Factom.

 

Factom's proposed plan of reorganisation includes an application for the discharge of various debts of Factom, including an application for the Court to set aside the obligations of Factom under FastFoward's $6 million SAFE note. The board of FastForward strongly opposes the proposed reorganisation of Factom on the terms proposed in Factom's proposed plan of reorganisation, and rejects claims made by Factom that FastForward is acting as a barrier to Factom raising capital. If Factom's case is not dismissed or converted, then FastForward will oppose the confirmation of any plan that would seek to discharge the SAFE note, whether in the Delaware Court or the Texas Court.

 

FastForward is represented in Factom's bankruptcy case by Seth Meisel of DuBois, Bryant & Campbell in Austin, Texas, and Daniel Astin of Ciardi, Ciardi & Astin, LLP in Wilmington, Delaware.

 

The Board of FastForward reserves its position in respect of any future legal action and will make further announcements as the court proceedings in the US progress and/ or new claims or and/ or new filings are submitted by Factom and/ or the Company.

 

The Company's interest in Factom is divided between Series Seed shares and the SAFE which were valued at £581,000 and £4,880,000 respectively as at 30 September 2019 but were subsequently written down to zero as announced on 14 April 2020 (to be reported at the next Balance Sheet date being 31 March 2020).

 

About FastForward Innovations Limited

FastForward innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

Cautionary Statement

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

 

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

*** ENDS***

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott / Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co

 

James Biddle / Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

 

Graham Dickson

Optiva Securities Limited,

Broker

 

Tel: +44 (0) 203 411 1881

 

Beth Melluish / Susie Geliher

St Brides Partners Ltd,

Financial PR

 

Tel: +44 (0)207 236 1177

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDGGDRCUGDGGI
Date   Source Headline
17th Nov 202010:30 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.
5th Nov 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
16th Oct 20209:00 amRNSInvestee Company Update: EMMAC Life Sciences
13th Oct 20207:00 amRNSPlacing and Issue of Equity
23rd Sep 20201:30 pmRNSInvestee Company Update: Yooma Corp.
23rd Sep 20207:00 amRNSHolding(s) in Company
22nd Sep 20207:00 amRNSChange of Broker
17th Sep 20203:45 pmRNSResult of AGM
16th Sep 20204:00 pmRNSInvestee Company Update: Juvenescence Limited
8th Sep 20204:00 pmRNSUpdated Key Information Document
27th Aug 20204:30 pmRNSInvestee Company Update: Factom Inc.
26th Aug 20207:30 amRNSNotice of AGM
26th Aug 20207:00 amRNSFinal Results
25th Aug 20202:30 pmRNSInvestee Company Update: Portage Biotech Inc.
24th Aug 20203:15 pmRNSInvestee Company Update: Leap Gaming
18th Aug 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
5th Aug 20207:00 amRNSInvestee Company Update: Leap Gaming
30th Jul 20208:52 amRNSInvestee Company Update: Factom Inc.
30th Jul 20207:45 amRNSInvestee Company Update: Portage Biotech Inc.
28th Jul 202011:55 amRNSInvestee Company Update: EMMAC Life Sciences
22nd Jul 20201:39 pmRNSInvestee Company Update: EMMAC Life Sciences
14th Jul 202010:15 amRNSInvestee Company Update: Yooma Corp.
13th Jul 20205:01 pmRNSResult of Extraordinary General Meeting
9th Jul 20207:00 amRNSInvestee Company Update: Factom Inc.
6th Jul 202010:31 amRNSInvestee Company Update: Leap Gaming
26th Jun 202012:30 pmRNSNotice of EGM & Proposed Updated Investing Policy
22nd Jun 20207:45 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:30 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:00 amRNSInvestee Company Update: Factom Inc.
17th Jun 20201:00 pmRNSInvestee Company Update: Portage Biotech Inc.
2nd Jun 20209:30 amRNSInvestee Company Update: Juvenescence Limited
26th May 20207:00 amRNSInvestee Company Update: Portage Biotech Inc
26th May 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
21st May 20207:00 amRNSInvestee Company Update: Leap Gaming
19th May 20207:30 amRNSInvestee Company Update: EMMAC Life Sciences
18th May 20207:00 amRNSInvestee Company Update re Yooma and Board Changes
12th May 202010:15 amRNSInvestee Company Update: Portage Biotech Inc.
6th May 202012:30 pmRNSInvestee Company Update: Portage Biotech Inc.
23rd Apr 20203:15 pmRNSInvestee Company Update: Entertainment Direct Asia
23rd Apr 20207:00 amRNSHolding(s) in Company
16th Apr 20204:15 pmRNSInvestee Company Update: Portage Biotech Inc.
16th Apr 20202:00 pmRNSInvestee Company Update: Portage Biotech Inc.
14th Apr 20207:00 amRNSCorporate Update
2nd Apr 20207:00 amRNSInvestee Company Update: Factom Inc.
1st Apr 20207:00 amRNSInvestee Company Update: Leap Gaming
31st Mar 20201:15 pmRNSInvestee Company Update: EMMAC Life Sciences
20th Mar 20205:04 pmRNSInvestee Company Update: Entertainment Direct Asia
19th Mar 20202:30 pmRNSInvestee Company Update: Factom Inc.
17th Mar 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.